Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients

被引:22
作者
Knerr, K
Füth, R
Hemsen, P
Mohné, W
Heinig, A
Kleophas, W
Scherbaum, WA
Martin, S
机构
[1] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, German Diabet Clin, D-40225 Dusseldorf, Germany
[2] Kuratorium Heimdialyse, Evangel Krankenhaus, Dusseldorf, Germany
[3] Diabet Schwerpunkttpraxis, Dusseldorf, Germany
关键词
cytokines; immune reactivity; leukocytes; mRNA; renal failure;
D O I
10.1016/j.cyto.2004.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunoincompetence is a profound problem in end-stage renal failure patients undergoing hemodialysis, and chronic inflammation with altered serum levels of inflammation markers has been reported. Gene expression patterns have had little relevance for leukocyte research so far because of limitations in transcript levels and stability. Using a new stimulation system we induced the expression of immune-relevant transcripts in whole blood preparations ex vivo and stabilized transcript levels by preventing RNA degradation and uncontrolled gene induction. Using quantitative real-time PCR we could show that basal TGF-beta mRNA expression is about 2-fold decreased in end-stage renal failure patients, while expression of TNF-alpha becomes 2-fold increased, further doubling during hemodialysis. By short term stimulation with phytohemagglutinin (PHA) for 2 h we tested for the immune competence of peripheral blood leukocytes and demonstrated that hemodialysis decreases TNF-alpha-mediated immune responsiveness more than 3-fold. This study shows by induction and stabilization of immune-relevant transcripts that chronic inflammation and hemodialysis are crucial factors for disturbed immune competence of end-stage renal failure patients. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 30 条
[1]   Immunological basis of inflammation in dialysis [J].
Amore, A ;
Coppo, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :16-24
[2]  
CHOLLETMARTIN S, 1991, CLIN EXP IMMUNOL, V83, P329
[3]   HEMODIALYSIS LEUKOPENIA - PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES [J].
CRADDOCK, PR ;
FEHR, J ;
DALMASSO, AP ;
BRIGHAM, KL ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :879-888
[4]   CELLULAR-IMMUNITY IN HEMODIALYSIS-PATIENTS - A QUANTITATIVE-ANALYSIS OF IMMUNE CELL SUBSETS BY FLOW-CYTOMETRY [J].
DEENITCHINA, SS ;
ANDO, T ;
OKUDA, S ;
KINUKAWA, N ;
HIRAKATA, H ;
NAGASHIMA, A ;
FUJISHIMA, M .
AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (01) :57-65
[5]   UREMIC SERUM EFFECTS ON PERIPHERAL-BLOOD MONONUCLEAR CELL AND PURIFIED LYMPHOCYTE-T RESPONSES [J].
DONATI, D ;
DEGIANNIS, D ;
RASKOVA, J ;
RASKA, K .
KIDNEY INTERNATIONAL, 1992, 42 (03) :681-689
[6]  
Esnault S, 1999, J IMMUNOL, V163, P5228
[7]   Evaluation of diagnostic relevance of mRNA levels in peripheral blood:: predictive value for mortality in hemodialysis patients [J].
Füth, R ;
Herder, C ;
Förster, S ;
Müller-Scholze, S ;
Kruse, N ;
Rieckmann, P ;
Heinig, A ;
Koenig, W ;
Scherbaum, WA ;
Kolb, H ;
Martin, S .
CYTOKINE, 2004, 27 (06) :166-172
[8]   T-CELL ACTIVATION DEFECT IN HEMODIALYSIS-PATIENTS - EVIDENCE FOR A ROLE OF THE B7/CD28 PATHWAY [J].
GIRNDT, M ;
KOHLER, H ;
SCHIEDHELMWEICK, E ;
ZUMBUSCHENFELDE, KHM ;
FLEISCHER, B .
KIDNEY INTERNATIONAL, 1993, 44 (02) :359-365
[9]   PRODUCTION OF INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-10 IN-VITRO CORRELATES WITH THE CLINICAL IMMUNE DEFECT IN CHRONIC-HEMODIALYSIS PATIENTS [J].
GIRNDT, M ;
KOHLER, H ;
SCHIEDHELMWEICK, E ;
SCHLAAK, JF ;
ZUMBUSCHENFELDE, KHM ;
FLEISCHER, B .
KIDNEY INTERNATIONAL, 1995, 47 (02) :559-565
[10]   Selective sequestration of cytokine-producing monocytes during hemodialysis treatment [J].
Girndt, M ;
Kaul, H ;
Leitnaker, CK ;
Sester, M ;
Sester, U ;
Köhler, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (05) :954-963